text version

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶The Turn Away (CaD 1 Ki 9)Wayfarer6:30Notes
   +Listen later
2. 2▶The Turn (CaD 1 Ki 8)Wayfarer6:41Notes
   +Listen later
3. 3▶The Pillars' Silent Reminder (CaD 1 Ki 7)Wayfarer7:12Notes
   +Listen later
4. 4▶Beneath the Blueprints (CaD 1 Ki 6)Wayfarer5:27Notes
   +Listen later
5. 5▶Temple and Stone (CaD 1 Ki 5)Wayfarer5:22Notes
   +Listen later
6. 6▶Inflection Point (CaD 1 Ki 4)Wayfarer6:47Notes
   +Listen later
7. 7▶New Excipient Products: Are They Coming?DCAT Value Chain Insights’ Production to Prescription31:41
   +Listen later
8. 8▶Solomon Didn't Ask for Wisdom (CaD 1 Ki 3)Wayfarer3:41Notes
   +Listen later
9. 9▶Direction and Mess (CaD 1 Ki 2)Wayfarer7:03Notes
   +Listen later
10. 10▶Two Sons, One Throne (CaD 1 Ki 1)Wayfarer7:30Notes
    +Listen later
11. 11▶Not "Happily Ever After" (CaD 2 Sam 24)Wayfarer7:27Notes
    +Listen later
12. 12▶Life and Legacy (CaD 2 Sam 23)Wayfarer7:43Notes
    +Listen later
13. 13▶End Theme (CaD 2 Sam 22)Wayfarer8:20Notes
    +Listen later
14. 14▶Addressing What's Broken (CaD 2 Sam 21)Wayfarer6:38Notes
    +Listen later
15. 15▶Pipeline Potential: Small-Molecule DrugsDCAT Value Chain Insights’ Production to Prescription20:11
    +Listen later
16. 16▶CDMO Outlook: Small Molecules—What Lies Ahead?DCAT Value Chain Insights’ Production to Prescription35:04
    +Listen later
17. 17▶A CDMO Roundtable: The Making of a Molecule: Peptide SynthesisDCAT Value Chain Insights’ Production to Prescription23:59
    +Listen later
18. 18▶What Tops the Industry’s Sustainability Agenda for 2026?DCAT Value Chain Insights’ Production to Prescription16:06
    +Listen later
19. 19▶2026 Outlook: CDMO Market for InjectablesDCAT Value Chain Insights’ Production to Prescription22:57
    +Listen later
20. 20▶2026: Drugs To Watch: The Year AheadDCAT Value Chain Insights’ Production to Prescription23:44
    +Listen later
21. 21▶2025: The Bio/Pharma Industry’s Year in ReviewDCAT Value Chain Insights’ Production to Prescription37:55
    +Listen later
22. 22▶What’s Trending: ADCs: Pipelines, Products, & CDMO GrowthDCAT Value Chain Insights’ Production to Prescription20:22
    +Listen later
23. 23▶Drug Launches & Approvals in 2025: The Blockbuster ContendersDCAT Value Chain Insights’ Production to Prescription17:19
    +Listen later